The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach

The development of novel regulatory tools such as adaptive clinical trial design and utilization of real-world evidence are topics of high interest. Recently, the European Medicines Agency (EMA) introduced the Adaptive Pathways (AP) that represents an innovative tool in healthcare systems allowing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicotera, Giuseppe, Sferrazza, Gianluca, Serafino, Annalucia, Pierimarchi, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610487/
https://www.ncbi.nlm.nih.gov/pubmed/31316991
http://dx.doi.org/10.3389/fmed.2019.00148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610487/
https://www.ncbi.nlm.nih.gov/pubmed/31316991
http://dx.doi.org/10.3389/fmed.2019.00148

Ejemplares similares